G. Sharbeen Et Al. , "Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition," CANCER RESEARCH , vol.81, no.13, pp.3461-3479, 2021
Sharbeen, G. Et Al. 2021. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition. CANCER RESEARCH , vol.81, no.13 , 3461-3479.
Sharbeen, G., McCarroll, J. A., Akerman, A., Kopecky, C., Youkhana, J., Kokkinos, J., ... Holst, J.(2021). Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition. CANCER RESEARCH , vol.81, no.13, 3461-3479.
Sharbeen, George Et Al. "Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition," CANCER RESEARCH , vol.81, no.13, 3461-3479, 2021
Sharbeen, George Et Al. "Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition." CANCER RESEARCH , vol.81, no.13, pp.3461-3479, 2021
Sharbeen, G. Et Al. (2021) . "Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition." CANCER RESEARCH , vol.81, no.13, pp.3461-3479.
@article{article, author={George Sharbeen Et Al. }, title={Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition}, journal={CANCER RESEARCH}, year=2021, pages={3461-3479} }